Real-time enrollment status for this langerhans cell histiocytosis clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 12:30 PM UTC
| NCT Number | NCT04079179 |
| Recruiting Status | Recruiting |
| Condition | Langerhans Cell Histiocytosis |
| Phase | PHASE2 |
| Target Enrollment | 90 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Carl Allen |
| Last Updated on CT.gov | September 18, 2025 (Sep 18, 2025) |
As of August 28, 2026: Clinical trial NCT04079179 is currently recruiting participants. This phase2 study for langerhans cell histiocytosis is actively seeking new participants at 12 locations across the United States. The study is sponsored by Carl Allen. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04079179 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04079179 was last updated Sep 18, 2025 (September 18, 2025). HelloStudys verifies this status automatically.